Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
@$35/sh would cost PFE $14.9B not $13.5B.
Mission Accomplished.
That means no PFE BO anytime soon.
There's no amount of money that HLS could afford that might be big enough to entice PFE. So it's not about money. Then it must be V hence Amarin the company.
For under $15B deal, BP rarely use company stock for acquisitions.
PFE will pay cash for any AMRN BO as the CEO don't want to piss off shareholders for any potential dilution.
My goal today is to make sure AMRN won't drop below the 200 day MA by buying more shares.
postes, for $35 stock price, assuming a PE of 12 (reasonable for a company with no pipeline and patent clock ticking), needs net income of $2.92/share or $1.3B (assuming 450M fully diluted shares outstanding due to continuous dilution until such profitability could be achieved). Assume 20% net margin, AMRN would need to have $6.5B in annual sales, tough to achieve IMO.
One of JT many blunders was the selling of the Canadian V right so cheaply to HLS. He could have made a deal with PFE Canada now and keep more profit.
Why nobody buying the stock for a guaranteed 3-bagger? If you knew the secret deal, some top performing hedgefunders got to know that too hence should drive up the stock price for some easy money.
Because JT's legal and marketing mismanagement has to pay a price hence the discount. Otherwise, JT's gamble would have been risk free.
Ns, it's just the first step for PFE to realize my dream of 1 AMRN = .3 PFE.
skip, IBB down 2.7% Vs Amrn down 3%, is there a leak for IBB too? I blame today's move on FFS turning bullish.
Here is the orginal AMRN/HLS agreeement,
"The agreement also provides for HLS to pay Amarin tiered double digit royalties on net sales of Vascepa in Canada."
https://investor.amarincorp.com/news-releases/news-release-details/amarin-and-hls-therapeutics-announce-agreement-commercialize
So this PFE news is very positive for AMRN as PFE should bring in more royalties than HLS going alone.
DAR, I just tried to point out that you didn't bother to vote and your first IHUB post was on Dec 2020. You have no basis for questioning my AMRN stock ownership.
Due to the delta variant, Taiwan started to experience more covid cases few months ago. Then they start to implement the appropriate measure again and cases start to come down again:
https://www.google.com/search?q=taiwan+covid+statistics&ei=0xsZYfbBAqSc_QaKzZTACA&oq=taiwan+covid+stati&gs_lcp=Cgdnd3Mtd2l6EAEYADIFCAAQgAQyBQgAEIAEMgYIABAWEB4yBggAEBYQHjIGCAAQFhAeMgUIABCGAzIFCAAQhgMyBQgAEIYDOgcIABBHELADOgcIABCwAxBDOggIABCABBCxAzoHCAAQsQMQQzoKCAAQsQMQyQMQQzoECAAQQzoFCAAQkQI6CAgAEIAEEMkDSgQIQRgAUNLFAljX0AJgldwCaAFwAngAgAFdiAGEBJIBATeYAQCgAQHIAQrAAQE&sclient=gws-wiz#wptab=s:H4sIAAAAAAAAAONgVuLVT9c3NMwySk6OL8zJecQYzy3w8sc9YamwSWtOXmMM4BL3TU3JTM7MS3XJLE5NLE71yU9OLMnMzxOS5mJzzSvJLKkUEpTi50I1RkiCiwOukEeKi4tDP1ffwCzN2IhnFxO3R2piTklGcEliSfEiVvGSxMzyxDyF5PyyzBSFYqBgZnFJZnIxAEXkMc-bAAAA
It's like turn on/off a light switch against covid. All citizens just need to cooperate and willing to sacrifice a bit and the crisis should soon be over.
https://thediplomat.com/2021/07/why-taiwan-is-beating-covid-19-again/
DAR, "don't think you are long on this stock"? That's because you just joined this board less than a year ago with less than 200 posts. I bet you didn't even cast the proxy vote this year.
Ns, different shareholder has different BO target price which is a function of how many shares he/she owned and how long he/she has held AMRN stock, i.e., the more shares owned and the longer the holding period, the lower the BO target price. For me, I am OK with $15/share. Ask the Baker Brothers, who are expert in biotech valualtion, they were willing to sell at much less than $15/share.
Those are potential rewards but in order to realize those everything has to go right. See my list of risks in my previous post.
The problem is no BP is offering $25 so shareholders have to risk GIA which is fraught with execution risk, dilution risk, competitive risk, economic risk, stock market risk and individual risk (health and well being). The way I look at it, due to JT's mismanagement (legal, marketing, option dilution, etc), the company is worth less to a would be acquirer now than the $24.12 closing high two years ago. Sometimes you just have to admit bad luck and defeat because that's the reality.
$26 was two years ago (actual closing high was $24.12 on 12/13/19). In the mean time, would be acquirer had already lost two years of US patent life so a discount from $26/$24 might not be unreasonable. Lastly, US market is not truly restored unless Du reinstates the MARINE patents or GV/GL left the market.
That's why KM has no choice but GIA since no BP is going to pay what you are looking for as the current BO bid ask spread is just too wide.
It's easy for you to say. PFE CEO has to convince potentially hostile shareholders about diluting their stock. To be honest, I'll take .3 share of PFE/AMRN share on merger Monday next week.
It's a great week for AMRN, able to close above the important 200 days MA for the first time in over 4 months. Let's hope for continued strong price action next week.
bio, the problem is Amarin last 12-months sales are only 1.1% of Pfizer's. Do you think PFE's shareholder would be happy to give away 7.7% of its equity in exchange for only 1.1% of its last 12-month revenue?
At this point, I blame the doctotrs more than I blame Amarin's marketing. What happen if the remaining 67% of doctors are too lazy/stubborn/non-receptive to learn about Vascepa? Perhaps those 67% of doctors have a strong belief that Vascepa is just over-priced fish oil similar to your strong belief that masks are ineffective against covid-19.
f, " 1 for 1"? That's why there won't be a Pfizer deal. You want too much especially a stock deal. Do you think PFE shareholders would be fine with additional 420M share dilution?
Is that why?
3 Top Penny Stocks on Robinhood Right Now
Amarin Corporation plc (NASDAQ: AMRN)
Cloopen Group Holding Limited (NYSE: RAAS)
Seanergy Maritime Holdings Corp. (NASDAQ: SHIP)
Amarin Corporation plc (NASDAQ: AMRN)
Amarin Corporation plc is a biotech penny stock that develops and commercializes therapeutics to treat cardiovascular diseases. It is currently developing VASCEPA which is for treating patients with severe hypertriglyceridemia. The company also has a collaboration with Mochida Pharmaceutical Co. Ltd. to develop and commercialize different drug products. Collaboration agreements in the biotech industry are one of the main ways for companies to stay ahead. It allows for faster development times and a degree of cost-sharing.
On August 5th, the company released a business update and its second quarter and six-month financial results. The company announced that its commercial launch of VAZKEPA in Europe is on track to start in September with Germany. The company’s revenue also increased by 14% year over year in this period. This is a substantial rise in revenue, and reflects the company’s hard work in launching its main commercial product.
“Amarin enters the second half of 2021 well positioned to deliver on our goals to reignite growth of branded VASCEPA in the U.S., to successfully launch VAZKEPA in Europe, and to undertake initiatives to expand its growth in other important geographies.”
https://pennystocks.com/featured/2021/08/12/top-penny-stocks-robinhood-buy-3-names-now/
I hope today's strong price performance has nothing to do with PREPARE-IT trial runup but rather BO, settlement or other positive legal developments.
postes, it's great for AMRN to have an outperformance over IBB after such a prolonged underperformance.
Could it be the stock goes up because of this:
@drpablocorral Alert the Media! PREPARE-IT & MITIGATE Cometh!
— Mike Everts (@GeoWizz_) August 10, 2021
Disclaimer: This is my slide and not approved by Amarin. pic.twitter.com/w9yimZ0N77
ramfan, unfortunately the country which has most citizens that think like you and raf, i.e., "the virus is gonna virus regardless of what we do" racks up the most Covid cases and deaths. Is there a correlation?
"USA masks up more than Malaysia?" No, higher US vaccination rate explains the situation.
Malaysia
Coronavirus Cases:
1,299,767
Deaths:
11,162
https://www.worldometers.info/coronavirus/country/malaysia/
United States
Coronavirus Cases:
36,840,179
Deaths:
634,437
https://www.worldometers.info/coronavirus/country/us/
Daily cases you pointed out can be explained by mask compliance rate of the respective countries, i.e., mask compliance rate in descending order:
Taiwan > Malaysia > Thailand > USA
I just try to point out that the Taiwan health officals, who know more about effective covid measures than both you and me, credit mask wearing as effective against covid from spreading.
Why Taiwan Is Beating COVID-19 – Again,
"First, Taiwan doubled down on longstanding strategies of masking, quarantine measures, and contact tracing. Long before this wave, as early as April 2020, Taiwan had already instituted mask mandates on public transportation. The government extended the mask mandate to everybody on the island and required its citizens to wear a mask outside their home."
https://thediplomat.com/2021/07/why-taiwan-is-beating-covid-19-again/
Did you forget GL?
MARINE patents, i.e., TG>500mg/dL, by definition, is for > 12weeks of treatment since it's a genetic disorder which reqires indefinite treatment.
"could be $40"? That's what I call pumping.